Celebrex: Targeted Relief for Osteoarthritis and Rheumatoid Arthritis
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.70 | $42.14 (0%) | 🛒 Add to cart |
| 90 | $0.60 | $63.21 $54.18 (14%) | 🛒 Add to cart |
| 120 | $0.54 | $84.28 $65.36 (22%) | 🛒 Add to cart |
| 180 | $0.50 | $126.42 $89.44 (29%) | 🛒 Add to cart |
| 270 | $0.47 | $189.63 $126.42 (33%) | 🛒 Add to cart |
| 360 | $0.45
Best per pill | $252.84 $162.54 (36%) | 🛒 Add to cart |
| Product dosage: 200mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.20 | $36.12 (0%) | 🛒 Add to cart |
| 60 | $0.85 | $72.24 $50.74 (30%) | 🛒 Add to cart |
| 90 | $0.73 | $108.36 $65.36 (40%) | 🛒 Add to cart |
| 120 | $0.67 | $144.48 $79.98 (45%) | 🛒 Add to cart |
| 180 | $0.62 | $216.72 $110.94 (49%) | 🛒 Add to cart |
| 270 | $0.57 | $325.08 $153.94 (53%) | 🛒 Add to cart |
| 360 | $0.55
Best per pill | $433.44 $199.52 (54%) | 🛒 Add to cart |
Synonyms
| |||
Celebrex (celecoxib) is a prescription nonsteroidal anti-inflammatory drug (NSAID) specifically formulated as a selective cyclooxygenase-2 (COX-2) inhibitor. It is indicated for the management of osteoarthritis (OA), rheumatoid arthritis (RA), ankylosing spondylitis, and acute pain in adults. Unlike traditional NSAIDs, which non-selectively inhibit both COX-1 and COX-2 enzymes, Celebrex provides anti-inflammatory and analgesic effects while offering a potentially improved gastrointestinal tolerability profile. It is a critical tool in the long-term management of chronic inflammatory conditions, helping to reduce pain and improve physical function.
Features
- Active Ingredient: Celecoxib
- Drug Class: Selective COX-2 inhibitor, NSAID
- Available Strengths: 50 mg, 100 mg, 200 mg, and 400 mg capsules
- Administration: Oral
- Mechanism of Action: Inhibits prostaglandin synthesis primarily via COX-2 enzyme blockade
- Prescription Status: Rx-only in most jurisdictions
Benefits
- Provides effective relief from chronic pain associated with osteoarthritis and rheumatoid arthritis.
- Reduces joint stiffness and swelling, improving mobility and quality of life.
- Offers a favorable gastrointestinal safety profile compared to non-selective NSAIDs.
- Allows for once or twice-daily dosing, supporting patient adherence.
- Does not inhibit platelet aggregation, eliminating the antiplatelet effects associated with non-selective NSAIDs.
- Suitable for long-term management of inflammatory conditions under appropriate medical supervision.
Common use
Celebrex is commonly prescribed for the management of signs and symptoms of osteoarthritis and rheumatoid arthritis in adults. It is also approved for the relief of acute pain, such as that following dental or orthopedic surgical procedures, and for the treatment of ankylosing spondylitis. In clinical practice, it is often utilized when patients require NSAID therapy but have a history of or risk factors for gastrointestinal adverse events, or when the antiplatelet effects of traditional NSAIDs are undesirable.
Dosage and direction
For osteoarthritis, the recommended dose is 200 mg per day, administered as a single dose or as 100 mg twice daily. For rheumatoid arthritis, the dose is 100 mg to 200 mg twice daily. For the management of acute pain or primary dysmenorrhea, the initial dose is 400 mg, followed by an additional 200 mg dose if needed on the first day, with subsequent dosing of 200 mg twice daily as required. For ankylosing spondylitis, the recommended dose is 200 mg daily in single or divided doses; if no effect is observed after 6 weeks, a trial of 400 mg daily may be considered. Celebrex should be taken with a full glass of water, and may be administered with or without food. The lowest effective dose should be used for the shortest duration consistent with individual patient treatment goals.
Precautions
Patients should be advised to promptly report any signs or symptoms of gastrointestinal ulceration or bleeding, such as epigastric pain, dyspepsia, melena, or hematemesis. Celebrex may lead to an increased risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal. This risk may increase with duration of use, and patients with cardiovascular disease or risk factors for cardiovascular disease may be at greater risk. Celebrex is contraindicated in the setting of coronary artery bypass graft (CABG) surgery. NSAIDs, including Celebrex, cause an increased risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Use with caution in patients with fluid retention, hypertension, or heart failure. Long-term administration of NSAIDs can result in renal papillary necrosis and other renal injury.
Contraindications
Celebrex is contraindicated in patients with known hypersensitivity to celecoxib. It should not be used in patients who have demonstrated allergic-type reactions to sulfonamides. Celebrex is contraindicated in patients who have experienced asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Severe, sometimes fatal, anaphylactic reactions to NSAIDs have been reported in such patients. It is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery. Celebrex should not be used during the third trimester of pregnancy as it may cause premature closure of the ductus arteriosus.
Possible side effect
Common adverse reactions (≥2% incidence) include headache, dyspepsia, upper respiratory tract infection, diarrhea, sinusitis, abdominal pain, and nausea. Serious side effects may include cardiovascular thrombotic events, gastrointestinal bleeding, ulceration, and perforation, hepatotoxicity (elevations of ALT and/or AST have been reported), hypertension, heart failure, renal toxicity, anaphylactic reactions, serious skin reactions, hematologic toxicity (anemia has been reported), and exacerbation of asthma. Patients should be monitored for these potential adverse effects.
Drug interaction
Celebrex metabolism is primarily mediated via cytochrome P450 2C9 (CYP2C9). Co-administration with drugs that inhibit CYP2C9 (e.g., fluconazole) may increase celecoxib plasma concentrations. Conversely, inducers of CYP2C9 may decrease celecoxib concentrations. Concomitant use with aspirin is not generally recommended because of the potential for increased risk of GI adverse events. Celebrex can reduce the anti-hypertensive effect of ACE inhibitors, angiotensin II receptor blockers (ARBs), and beta-blockers. Concomitant administration with warfarin may lead to increased prothrombin time and risk of bleeding. NSAIDs may diminish the antihypertensive effect of diuretics. Concomitant use of Celebrex with other NSAIDs or corticosteroids may increase the risk of GI toxicity.
Missed dose
If a dose is missed, it should be taken as soon as remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped and the regular dosing schedule resumed. Doubling the dose to make up for a missed one is not recommended.
Overdose
Symptoms of overdose may include lethargy, drowsiness, nausea, vomiting, epigastric pain, gastrointestinal bleeding, hypertension, acute renal failure, respiratory depression, coma, or anaphylaxis. There is no specific antidote for celecoxib overdose. Management should be supportive and symptomatic. In cases of acute overdose, gastric lavage and administration of activated charcoal may be considered. Hemodialysis is not likely to be effective in removing celecoxib due to its high protein binding.
Storage
Store at room temperature, 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). Keep in the original container, tightly closed, and protect from moisture and light. Keep out of reach of children and pets.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The information provided is based on the manufacturer’s prescribing information but may not be exhaustive. Individual patient response and risks may vary.
Reviews
Clinical studies and post-marketing surveillance have demonstrated Celebrex’s efficacy in reducing pain and improving function in patients with osteoarthritis and rheumatoid arthritis. Many patients report significant improvement in daily activities and quality of life. However, as with all NSAIDs, the potential for serious cardiovascular and gastrointestinal events requires that it be used at the lowest effective dose for the shortest possible duration. Patient selection and ongoing monitoring are paramount.